NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)

Historical Portfolio Holders from Q4 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / ORDINARY SHARES
Shares, excl. options Q3 2024
225K
Holdings value Q3 2024
$286K
Value change Q3 2024
-$1.6M
Grand Portfolio weight change Q3 2024
0%
Number of holders
7
Number of buys Q3 2024
4
Number of sells Q3 2024
-3
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 225K $286K -$1.6M $1.27 7
2024 Q2 1.67M $1.87M +$1.61M $1.12 7
2024 Q1 167K $304K +$74.4K $1.82 8
2023 Q4 142K $111K -$461K $0.79 8
2023 Q3 779K $554K -$581K $0.71 5
2023 Q2 1.47M $2.2M +$2.01M $1.49 6
2023 Q1 124K $243K +$193K $1.74 5
2022 Q4 34.7K $41.6K -$46.6K $1.22 5
2022 Q3 73.7K $132K -$516K $1.80 4
2022 Q2 217K $733K +$65.7K $3.37 7
2022 Q1 169K $694K +$265K $3.94 7
2021 Q4 155K $380K +$380K $2.45 5